- Home
- IRON vs AMPL Comparison
IRON vs AMPL Comparison
Compare IRON & AMPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- AMPL
- Stock Information
- Founded
- IRON 2017
- AMPL 2012
- Country
- IRON United States
- AMPL United States
- Employees
- IRON N/A
- AMPL N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- AMPL EDP Services
- Sector
- IRON Health Care
- AMPL Technology
- Exchange
- IRON Nasdaq
- AMPL Nasdaq
- Market Cap
- IRON 1.4B
- AMPL 1.5B
- IPO Year
- IRON N/A
- AMPL 2021
- Fundamental
- Price
- IRON $46.68
- AMPL $12.48
- Analyst Decision
- IRON Strong Buy
- AMPL Buy
- Analyst Count
- IRON 9
- AMPL 10
- Target Price
- IRON $93.89
- AMPL $13.50
- AVG Volume (30 Days)
- IRON 354.8K
- AMPL 1.8M
- Earning Date
- IRON 05-07-2025
- AMPL 05-07-2025
- Dividend Yield
- IRON N/A
- AMPL N/A
- EPS Growth
- IRON N/A
- AMPL N/A
- EPS
- IRON N/A
- AMPL N/A
- Revenue
- IRON N/A
- AMPL $306,601,000.00
- Revenue This Year
- IRON N/A
- AMPL $12.82
- Revenue Next Year
- IRON N/A
- AMPL $10.82
- P/E Ratio
- IRON N/A
- AMPL N/A
- Revenue Growth
- IRON N/A
- AMPL 8.56
- 52 Week Low
- IRON $30.82
- AMPL $7.37
- 52 Week High
- IRON $68.73
- AMPL $14.88
- Technical
- Relative Strength Index (RSI)
- IRON 49.90
- AMPL 61.97
- Support Level
- IRON $44.85
- AMPL $11.78
- Resistance Level
- IRON $47.36
- AMPL $12.79
- Average True Range (ATR)
- IRON 2.23
- AMPL 0.53
- MACD
- IRON -0.12
- AMPL 0.04
- Stochastic Oscillator
- IRON 37.58
- AMPL 73.36
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About AMPL Amplitude Inc.
Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue primarily through selling subscriptions to the platform. The company derives a majority of its revenue from the United States.